“Startup Big Health believes individuals can improve their mental health through its technology that focuses on cognitive behavioral therapy versus medication or the help of human therapists.
On Thursday it raised $39 million in a Series B financing to advance that objective.
Its two digital offerings, Daylight, for worry and anxiety, and Sleepio, for poor sleep, are fully automated cognitive and behavioral programs.
“We are taking proven cognitive behavioral therapies and fully automating them to deliver the care scalably and consistently as drugs,” Peter Hames, co-founder and CEO, told Crunchbase News. “Clinical studies show these kinds of products are just as effective as medication and people.”
Gilde Healthcare led the new round of funding joined by co-lead Morningside Ventures, as well as Samsung NEXT and existing investors Kaiser Permanente Ventures and Octopus Ventures. The new funding gives San Francisco-based Big Health a total raise of $54.3 million since the company was founded in 2010.
News in Context:
- CVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills
- Digital health start-ups raised a record $3.1 billion in Q1; focus will likely evolve from providers to consumers and employers
- Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health
- FDA clears first CBT-based digital therapeutic to treat substance abuse disorders
- The FDA creates new Digital Health unit to reimagine regulatory paths in the age of scalable, AI-enhanced innovation
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright